29 209

Cited 0 times in

False negative F-18 FDG PET/CT in nonsmall cell lung cancer bone metastases.

An, YS; Yoon, JK; Lee, MH; Joh, CW; Yoon, SN
Clinical nuclear medicine, 30(3):203-204, 2005
Journal Title
Clinical nuclear medicine
Tc-99m MDP bone scintigraphy is frequently performed for suspected skeletal metastases in lung cancer. F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) has also proved useful for staging nonsmall cell lung cancer, and it offers superior spatial resolution and improved specificity for bone metastases. Although F-18 FDG-PET is superior to Tc-99m MDP bone scintigraphy for the detection of bone metastases, the sensitivity for sclerotic (osteoblastic) metastases by F-18 FDG PET/CT is lower than for lytic metastases. These bone metastases may not be glycolytically active and may be below the requisite tumor mass needed for FDG accumulation. We describe the case of false-negative F-18 FDG PET/CT findings in a 57-year-old woman who demonstrated sclerotic bone metastases from nonsmall cell lung cancer. F-18 fluoride PET demonstrates a similar uptake pattern as Tc-99m MDP.
MeSH terms
Bone Neoplasms/radionuclide imaging*Bone Neoplasms/secondary*Carcinoma, Non-Small-Cell Lung/radionuclide imaging*Carcinoma, Non-Small-Cell Lung/secondary*False Negative ReactionsFemaleFluorodeoxyglucose F18/diagnostic use*HumansLung Neoplasms/radionuclide imaging*Middle AgedPositron-Emission Tomography/methodsRadiopharmaceuticals/diagnostic useSubtraction Technique*Technetium Tc 99m Medronate/diagnostic use*Tomography, X-Ray Computed/methods
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Nuclear Medicine & Molecular Imaging
AJOU Authors
윤, 준기조, 철우윤, 석남
Full Text Link
RIS (EndNote)
XLS (Excel)


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.